SANUWAVE Health Correlations
SNWV Stock | USD 20.24 2.76 12.00% |
The current 90-days correlation between SANUWAVE Health and Grey Cloak Tech is -0.13 (i.e., Good diversification). The correlation of SANUWAVE Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
SANUWAVE Health Correlation With Market
Average diversification
The correlation between SANUWAVE Health and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding SANUWAVE Health and DJI in the same portfolio, assuming nothing else is changed.
SANUWAVE |
The ability to find closely correlated positions to SANUWAVE Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace SANUWAVE Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back SANUWAVE Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling SANUWAVE Health to buy it.
Moving together with SANUWAVE OTC Stock
0.81 | DIS | Walt Disney | PairCorr |
0.92 | CSCO | Cisco Systems | PairCorr |
0.79 | T | ATT Inc Fiscal Year End 22nd of January 2025 | PairCorr |
0.92 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
0.82 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
Moving against SANUWAVE OTC Stock
0.94 | KO | Coca Cola Fiscal Year End 11th of February 2025 | PairCorr |
0.94 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.92 | PPERY | Bank Mandiri Persero | PairCorr |
0.92 | BKRKY | Bank Rakyat | PairCorr |
0.84 | PPERF | Bank Mandiri Persero | PairCorr |
0.84 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.79 | PBCRY | Bank Central Asia | PairCorr |
0.77 | PTBRY | Bank Negara Indonesia | PairCorr |
0.74 | BKRKF | PT Bank Rakyat | PairCorr |
0.68 | SHG | Shinhan Financial | PairCorr |
0.6 | PBCRF | PT Bank Central | PairCorr |
0.53 | VZ | Verizon Communications Fiscal Year End 28th of January 2025 | PairCorr |
0.5 | MMM | 3M Company Fiscal Year End 28th of January 2025 | PairCorr |
0.48 | WF | Woori Financial Group | PairCorr |
0.44 | GE | GE Aerospace Fiscal Year End 28th of January 2025 | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between SANUWAVE OTC Stock performing well and SANUWAVE Health OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze SANUWAVE Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
HYEX | 6.72 | 0.91 | 0.03 | (0.94) | 9.35 | 25.00 | 85.95 | |||
CSTF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
WRHLF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
GCAN | 8.48 | 0.67 | 0.02 | (0.43) | 9.62 | 25.00 | 68.57 | |||
GXXY | 5.52 | (1.45) | 0.00 | (0.82) | 0.00 | 19.05 | 67.08 | |||
GSAC | 9.60 | 1.52 | 0.06 | 1.38 | 10.03 | 33.33 | 58.33 | |||
NUNZ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
NUGS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
MNFSF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
PHCG | 15.13 | 5.16 | 0.09 | (0.51) | 13.13 | 100.00 | 150.00 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in SANUWAVE Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
All Next | Launch Module |
SANUWAVE Health Corporate Management
Elected by the shareholders, the SANUWAVE Health's board of directors comprises two types of representatives: SANUWAVE Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SANUWAVE. The board's role is to monitor SANUWAVE Health's management team and ensure that shareholders' interests are well served. SANUWAVE Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SANUWAVE Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Iulian Cioanta | Chief Officer | Profile | |
Jack Schlechtweg | Chief Officer | Profile | |
MBA MBA | Chief Officer | Profile | |
Kevin II | CEO Director | Profile | |
Peter Stegagno | Chief Officer | Profile |